Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Meet The Zuckerman Spaeder Attys In Drug Rebate Battle No Photo Available

Gianna Ferrarin

A pair of Zuckerman Spaeder LLP attorneys who once oversaw changes to the 340B drug discount program during the Obama administration h... (more story)

Healthcare Deals This Week: Bayer, Novartis, Circle Pharma No Photo Available

Gianna Ferrarin

The precision oncology industry saw an increase in investment this past week as Noetik secured $40 million in financing for AI-driven ... (more story)

Will Medicaid Incarceration Waivers Hit 'Cutting Room Floor'? No Photo Available

Mark Payne

A bipartisan push to get incarcerated individuals covered by Medicaid before they're released could drastically reduce healthcare disp... (more story)